Ownership history in BVF INC/IL · 18 quarters on record
This page tracks every 13F SEC filing in which BVF INC/IL reported a position in NEKTAR THERAPUTICS COM (NKTR). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 1,559,595 | +283,000 | +22.2% | 2.22% | $65.9M | $42.28 |
| 2025 Q3 | REDUCED | 1,276,595 | -1,458,129 | -53.3% | 2.94% | $72.6M | $56.90 |
| 2012 Q4 | REDUCED | 2,734,724 | -1,472,100 | -35.0% | 3.84% | $20.3M | $111.15 |
| 2012 Q3 | REDUCED | 4,206,824 | -3,185,801 | -43.1% | 9.22% | $44.9M | $160.20 |
| 2012 Q2 | REDUCED | 7,392,625 | -246,375 | -3.2% | 14.92% | $59.7M | $121.05 |
| 2012 Q1 | UNCHANGED | 7,639,000 | — | 0% | 23.04% | $60.5M | $118.80 |
| 2011 Q4 | ADDED | 7,639,000 | +6,838,700 | +854.5% | 14.81% | $42.7M | $84.00 |
| 2011 Q3 | ADDED | 800,300 | +274,800 | +52.3% | 1.63% | $3.9M | $72.75 |
| 2009 Q4 | UNCHANGED | 525,500 | — | 0% | 1.51% | $4.9M | $139.80 |
| 2009 Q3 | REDUCED | 525,500 | -4,890,900 | -90.3% | 1.13% | $5.1M | $146.10 |
As of 2025 Q4 — sorted by position size